# A Study to Learn About Study Medicine Called Berobenatide in Adults With Knee Pain and Overweight or Obesity (VESPER-OA 1)

> **NCT07919678** · PHASE3 · RECRUITING · sponsor: **Pfizer** · enrollment: 656 (estimated)

## Conditions studied

- Obesity
- Overweight
- Osteoarthritis of the Knee

## Interventions

- **DRUG:** Berobenatide
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT07919678
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-10-26
- **Primary completion:** 2028-08-22
- **Final completion:** 2028-10-10
- **Target enrollment:** 656 (ESTIMATED)
- **Last updated:** 2026-11-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07919678

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07919678, "A Study to Learn About Study Medicine Called Berobenatide in Adults With Knee Pain and Overweight or Obesity (VESPER-OA 1)". Retrieved via MORVS 2026-11-22 from https://api.morvs.ai/clinical/NCT07919678. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
